Avaxim

Avaxim is a vaccine designed to protect against hepatitis A, a viral liver infection. It contains inactivated hepatitis A virus and is administered via intramuscular or subcutaneous injection.

Avaxim is primarily used for the prevention of hepatitis A, a contagious liver disease caused by the hepatitis A virus. It is often recommended for individuals traveling to regions where the virus is prevalent, as well as for those who may be at higher risk of exposure. The vaccine works by stimulating the body's immune system to produce antibodies against the virus, providing long-term protection.

Common effects of Avaxim may include mild soreness, redness, or swelling at the injection site. Some individuals might experience temporary fatigue, headache, or low-grade fever following vaccination. These effects are generally mild and short-lived.

Avaxim should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid it. It is important to inform the healthcare provider about any current medications or health conditions before receiving the vaccine.

Avaxim may interact with certain medications or other vaccines. It is advisable to discuss any ongoing treatments with a healthcare provider before receiving the vaccine. Additionally, individuals should avoid alcohol immediately before and after vaccination, as it may affect the body's immune response.